Cargando…
SAT-140 A Drug-Drug Interaction Trial of Oral Semaglutide with Levothyroxine and Multiple Coadministered Tablets
Introduction: Oral semaglutide contains the GLP-1 analog semaglutide co-formulated with the absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). Aims: This trial investigated (A) the effect of oral semaglutide and SNAC alone on the pharmacokinetics (PK) of levothyroxine (thyr...
Autores principales: | Hauge, Camilla, Breitschaft, Astrid, Hartoft-Nielsen, Marie-Louise, Jensen, Simon, Bækdal, Tine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552044/ http://dx.doi.org/10.1210/js.2019-SAT-140 |
Ejemplares similares
-
SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial
por: Rosenstock, Julio, et al.
Publicado: (2019) -
SAT-670 The Perfect Storm for Diabetic Ketoacidosis
por: Abushamat, Layla A, et al.
Publicado: (2020) -
SAT-679 Autoimmune Hypoglycemia: A Treatment Challenge
por: Santana, Nadyeschka Angelique Rivera, et al.
Publicado: (2020) -
SUN-140 The Ways of Achievement the Target Levels of Glycemic Control in Children and Adolescents with Type 1 Diabetes
por: Muz, Nataliia, et al.
Publicado: (2019) -
SAT-646 Do Diabetes and Hypertension Mobile Apps Overlap?
por: Wong, Jonathan, et al.
Publicado: (2020)